StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.72+0.06 (+3.61%)

Close on Nov 18, 2026Market cap $4.37MP/E –Yield –

Alaunos Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Alaunos Therapeutics's price to book ratio was 6.1× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.9× to 13.2×, with a median of 3.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.1×+3.6
2025Dec 31, 20252.5×+1.4
2024Dec 31, 20241.1×−0.1
2023Dec 29, 20231.2×−3.2
2022Dec 30, 20224.4×+0.9
2021Dec 31, 20213.4×−0.3
2020Dec 31, 20203.7×−4.3
2019Dec 31, 20198.1×−0.2
2016Jul 29, 20168.2×−3.4
2015Dec 31, 201511.6×−2.7
2014Dec 31, 201414.3×−85.7
2013Dec 31, 2013100.0×+94.4
2012Dec 31, 20125.6×+2.0
2011Dec 30, 20113.6×−1.8
2010Dec 31, 20105.4×–

More Alaunos Therapeutics figures

See a number that looks wrong?